Is Solid Biosciences Inc. (SLDB) a Buy, Sell, or Hold?
Solid Biosciences Inc.
NASDAQ:SLDB
$9.6263 USD
$0.0 (-0.04%)
- Volume
- 562.93K
- Average Volume
- 1.7M
- Market Capitalization
- $749.99M
- P/E Ratio
- -4.94
- Dividend Yield
- 0.00%
- Price Target
- $17.00
- Year High
- $11.45
- Year Low
- $3.79
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $13.10
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
79
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
61
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 1.37M
SLDB Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
SLDB Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| SMITH IAN F | director | 2026-07-02 | M-Exempt | 0 | 2026-07-07 |
| SMITH IAN F | director | 2026-07-02 | M-Exempt | 0 | 2026-07-07 |
| RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | 2026-06-22 | 0 | 2026-06-24 | |
| RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | 2026-06-22 | 0 | 2026-06-24 | |
| RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | 2026-06-22 | 0 | 2026-06-24 | |
| RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | 2026-06-22 | 0.001 | 2026-06-24 | |
| Nagendran Sukumar | director | 2026-06-10 | A-Award | 6.61 | 2026-06-11 |
| SMITH IAN F | director | 2026-06-10 | A-Award | 6.61 | 2026-06-11 |
| Ganot Ilan | director | 2026-06-10 | A-Award | 6.61 | 2026-06-11 |
| PERCEPTIVE ADVISORS LLC | director, 10 percent owner: | 2026-06-10 | A-Award | 6.61 | 2026-06-11 |
| Keresty Georgia | director | 2026-06-10 | A-Award | 6.61 | 2026-06-11 |
| Freed Martin I | director | 2026-06-10 | A-Award | 6.61 | 2026-06-11 |
| Kahn Clare | director | 2026-06-10 | A-Award | 6.61 | 2026-06-11 |
| Sullivan Lynne Marie | director | 2026-06-10 | A-Award | 6.61 | 2026-06-11 |
| Stone Adam Leo | director | 2026-06-10 | A-Award | 6.61 | 2026-06-11 |
| Howton David T | officer: Chief Operating Officer | 2026-01-29 | A-Award | 0 | 2026-04-21 |
| Brooks Gabriel | officer: Chief Medical Officer | 2026-01-29 | A-Award | 0 | 2026-04-21 |
| Cumbo Alexander | director, officer: President and CEO | 2026-01-29 | A-Award | 0 | 2026-04-21 |
| Herzich Paul | officer: Chief Technology Officer | 2026-01-29 | A-Award | 0 | 2026-04-21 |
| Tan Kevin | officer: CFO & Treasurer | 2026-01-29 | A-Award | 0 | 2026-04-21 |
| Hanrahan Jessie | officer: Chief Regulatory Officer | 2026-01-29 | A-Award | 0 | 2026-04-21 |
| SMITH IAN F | director | 2026-04-02 | M-Exempt | 0 | 2026-04-02 |
| SMITH IAN F | director | 2026-04-02 | M-Exempt | 0 | 2026-04-02 |
| PERCEPTIVE ADVISORS LLC | director, 10 percent owner: | 2026-03-09 | A-Award | 0.001 | 2026-03-11 |
| Cumbo Alexander | director, officer: President and CEO | 2026-02-13 | M-Exempt | 0 | 2026-02-18 |
| Cumbo Alexander | director, officer: President and CEO | 2026-02-18 | S-Sale | 5.8233 | 2026-02-18 |
| Cumbo Alexander | director, officer: President and CEO | 2026-02-13 | M-Exempt | 0 | 2026-02-18 |
| Hanrahan Jessie | officer: Chief Regulatory Officer | 2026-02-13 | M-Exempt | 0 | 2026-02-18 |
| Hanrahan Jessie | officer: Chief Regulatory Officer | 2026-02-18 | S-Sale | 5.8233 | 2026-02-18 |
| Hanrahan Jessie | officer: Chief Regulatory Officer | 2026-02-13 | M-Exempt | 0 | 2026-02-18 |
| Ganot Ilan | director | 2026-02-13 | M-Exempt | 0 | 2026-02-18 |
| Ganot Ilan | director | 2026-02-18 | S-Sale | 5.8233 | 2026-02-18 |
| Ganot Ilan | director | 2026-02-13 | M-Exempt | 0 | 2026-02-18 |
| Herzich Paul | officer: Chief Technology Officer | 2026-02-13 | M-Exempt | 0 | 2026-02-18 |
| Herzich Paul | officer: Chief Technology Officer | 2026-02-18 | S-Sale | 5.8233 | 2026-02-18 |
| Herzich Paul | officer: Chief Technology Officer | 2026-02-13 | M-Exempt | 0 | 2026-02-18 |
| Howton David T | officer: Chief Operating Officer | 2026-02-13 | M-Exempt | 0 | 2026-02-18 |
| Howton David T | officer: Chief Operating Officer | 2026-02-18 | S-Sale | 5.8233 | 2026-02-18 |
| Howton David T | officer: Chief Operating Officer | 2026-02-13 | M-Exempt | 0 | 2026-02-18 |
| Brooks Gabriel | officer: Chief Medical Officer | 2026-02-13 | M-Exempt | 0 | 2026-02-18 |
| Brooks Gabriel | officer: Chief Medical Officer | 2026-02-18 | S-Sale | 5.8233 | 2026-02-18 |
| Brooks Gabriel | officer: Chief Medical Officer | 2026-02-13 | M-Exempt | 0 | 2026-02-18 |
| Tan Kevin | officer: CFO & Treasurer | 2026-02-13 | M-Exempt | 0 | 2026-02-18 |
| Tan Kevin | officer: CFO & Treasurer | 2026-02-18 | S-Sale | 5.8233 | 2026-02-18 |
| Tan Kevin | officer: CFO & Treasurer | 2026-02-13 | M-Exempt | 0 | 2026-02-18 |
| Howton David T | officer: Chief Operating Officer | 2026-02-04 | S-Sale | 6.4419 | 2026-02-06 |
| Cumbo Alexander | director, officer: President and CEO | 2026-02-04 | S-Sale | 6.4419 | 2026-02-06 |
| Ganot Ilan | director | 2026-02-04 | S-Sale | 6.4419 | 2026-02-06 |
| Tan Kevin | officer: CFO & Treasurer | 2026-02-04 | S-Sale | 6.4419 | 2026-02-06 |
| Brooks Gabriel | officer: Chief Medical Officer | 2026-02-04 | S-Sale | 6.4419 | 2026-02-06 |
| Hanrahan Jessie | officer: Chief Regulatory Officer | 2026-02-04 | S-Sale | 6.4419 | 2026-02-06 |
| Herzich Paul | officer: Chief Technology Officer | 2026-02-04 | S-Sale | 6.4419 | 2026-02-06 |
| Tan Kevin | officer: CFO & Treasurer | 2026-01-29 | A-Award | 6.6 | 2026-02-02 |
| Tan Kevin | officer: CFO & Treasurer | 2026-01-31 | M-Exempt | 0 | 2026-02-02 |
| Tan Kevin | officer: CFO & Treasurer | 2026-02-02 | S-Sale | 6.4369 | 2026-02-02 |
| Tan Kevin | officer: CFO & Treasurer | 2026-01-29 | M-Exempt | 0 | 2026-02-02 |
| Tan Kevin | officer: CFO & Treasurer | 2026-01-31 | M-Exempt | 0 | 2026-02-02 |
| Tan Kevin | officer: CFO & Treasurer | 2026-01-29 | A-Award | 0 | 2026-02-02 |
| Tan Kevin | officer: CFO & Treasurer | 2026-01-29 | M-Exempt | 0 | 2026-02-02 |
| Cumbo Alexander | director, officer: President and CEO | 2026-01-29 | A-Award | 6.6 | 2026-02-02 |
| Cumbo Alexander | director, officer: President and CEO | 2026-01-31 | M-Exempt | 0 | 2026-02-02 |
| Cumbo Alexander | director, officer: President and CEO | 2026-01-31 | M-Exempt | 0 | 2026-02-02 |
| Cumbo Alexander | director, officer: President and CEO | 2026-02-02 | S-Sale | 6.4369 | 2026-02-02 |
| Cumbo Alexander | director, officer: President and CEO | 2026-01-29 | A-Award | 0 | 2026-02-02 |
| Cumbo Alexander | director, officer: President and CEO | 2026-01-29 | M-Exempt | 0 | 2026-02-02 |
| Cumbo Alexander | director, officer: President and CEO | 2026-01-29 | M-Exempt | 0 | 2026-02-02 |
| Hanrahan Jessie | officer: Chief Regulatory Officer | 2026-01-29 | A-Award | 6.6 | 2026-02-02 |
| Hanrahan Jessie | officer: Chief Regulatory Officer | 2026-01-31 | M-Exempt | 0 | 2026-02-02 |
| Hanrahan Jessie | officer: Chief Regulatory Officer | 2026-01-29 | A-Award | 0 | 2026-02-02 |
| Hanrahan Jessie | officer: Chief Regulatory Officer | 2026-01-31 | M-Exempt | 0 | 2026-02-02 |
| Hanrahan Jessie | officer: Chief Regulatory Officer | 2026-02-02 | S-Sale | 6.4369 | 2026-02-02 |
| Hanrahan Jessie | officer: Chief Regulatory Officer | 2026-01-29 | M-Exempt | 0 | 2026-02-02 |
| Hanrahan Jessie | officer: Chief Regulatory Officer | 2026-01-29 | M-Exempt | 0 | 2026-02-02 |
| Brooks Gabriel | officer: Chief Medical Officer | 2026-01-29 | A-Award | 6.6 | 2026-02-02 |
| Brooks Gabriel | officer: Chief Medical Officer | 2026-01-31 | M-Exempt | 0 | 2026-02-02 |
| Brooks Gabriel | officer: Chief Medical Officer | 2026-01-29 | A-Award | 0 | 2026-02-02 |
| Brooks Gabriel | officer: Chief Medical Officer | 2026-01-29 | M-Exempt | 0 | 2026-02-02 |
| Brooks Gabriel | officer: Chief Medical Officer | 2026-02-02 | S-Sale | 6.4369 | 2026-02-02 |
| Brooks Gabriel | officer: Chief Medical Officer | 2026-01-31 | M-Exempt | 0 | 2026-02-02 |
| Brooks Gabriel | officer: Chief Medical Officer | 2026-01-29 | M-Exempt | 0 | 2026-02-02 |
| Howton David T | officer: Chief Operating Officer | 2026-01-29 | A-Award | 6.6 | 2026-02-02 |
| Howton David T | officer: Chief Operating Officer | 2026-01-31 | M-Exempt | 0 | 2026-02-02 |
| Howton David T | officer: Chief Operating Officer | 2026-01-31 | M-Exempt | 0 | 2026-02-02 |
| Howton David T | officer: Chief Operating Officer | 2026-02-02 | S-Sale | 6.4369 | 2026-02-02 |
| Howton David T | officer: Chief Operating Officer | 2026-01-29 | M-Exempt | 0 | 2026-02-02 |
| Howton David T | officer: Chief Operating Officer | 2026-01-29 | A-Award | 0 | 2026-02-02 |
| Howton David T | officer: Chief Operating Officer | 2026-01-29 | M-Exempt | 0 | 2026-02-02 |
| Herzich Paul | officer: Chief Technology Officer | 2026-01-29 | A-Award | 6.6 | 2026-02-02 |
| Herzich Paul | officer: Chief Technology Officer | 2026-01-31 | M-Exempt | 0 | 2026-02-02 |
| Herzich Paul | officer: Chief Technology Officer | 2026-01-29 | A-Award | 0 | 2026-02-02 |
| Herzich Paul | officer: Chief Technology Officer | 2026-01-29 | M-Exempt | 0 | 2026-02-02 |
| Herzich Paul | officer: Chief Technology Officer | 2026-02-02 | S-Sale | 6.4369 | 2026-02-02 |
| Herzich Paul | officer: Chief Technology Officer | 2026-01-31 | M-Exempt | 0 | 2026-02-02 |
| Herzich Paul | officer: Chief Technology Officer | 2026-01-29 | M-Exempt | 0 | 2026-02-02 |
| Ganot Ilan | director | 2026-01-29 | A-Award | 6.6 | 2026-02-02 |
| Ganot Ilan | director | 2026-01-31 | M-Exempt | 0 | 2026-02-02 |
| Ganot Ilan | director | 2026-01-29 | A-Award | 0 | 2026-02-02 |
| Ganot Ilan | director | 2026-01-31 | M-Exempt | 0 | 2026-02-02 |
| Ganot Ilan | director | 2026-01-27 | M-Exempt | 0 | 2026-01-30 |
| Ganot Ilan | director | 2026-01-27 | M-Exempt | 0 | 2026-01-30 |